N-CAFFEOYLDOPAMINE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C17H17NO5
Molecular Weight	315.3206
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

SMILES

OC1=CC=C(CCNC(=O)\C=C\C2=CC(O)=C(O)C=C2)C=C1O

InChI

InChIKey=FSMGGLPUXCKRGT-ZZXKWVIFSA-N

InChI=1S/C17H17NO5/c19-13-4-1-11(9-15(13)21)3-6-17(23)18-8-7-12-2-5-14(20)16(22)10-12/h1-6,9-10,19-22H,7-8H2,(H,18,23)/b6-3+

HIDE SMILES / InChI

Molecular Formula	C17H17NO5
Molecular Weight	315.3206
Charge	0
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	1
Optical Activity	NONE

Approval Year

Substance Class	Chemical
Record UNII	HEM1G2VY70
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

N-CAFFEOYLDOPAMINE

Common Name

English

2-PROPENAMIDE, 3-(3,4-DIHYDROXYPHENYL)-N-(2-(3,4-DIHYDROXYPHENYL)ETHYL)-

Systematic Name

English

CAFFEDYMINE

Common Name

English

(2E)-3-(3,4-DIHYDROXYPHENYL)-N-(2-(3,4-DIHYDROXYPHENYL)ETHYL)-2-PROPENAMIDE

Systematic Name

English

2-PROPENAMIDE, 3-(3,4-DIHYDROXYPHENYL)-N-(2-(3,4-DIHYDROXYPHENYL)ETHYL)-, (2E)-

Systematic Name

English

Showing 1 to 5 of 5 entries

Previous1Next

Show entries

Classification Tree

Code System

Code

TBD

DSLD

2238 (Number of products:2)

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

FDA UNII

HEM1G2VY70

PRIMARY

CAS

103188-49-4

PRIMARY

CAS

105955-00-8

NON-SPECIFIC STEREOCHEMISTRY

PUBCHEM

10171904

PRIMARY

EPA CompTox

DTXSID00735426

PRIMARY

Showing 1 to 5 of 5 entries

Previous1Next

Show entries

Related Record

Type

Details


					0PDN17832A

IPOMOEA AQUATICA LEAF

PARENT -> CONSTITUENT ALWAYS PRESENT

Comments:

270 uM IC50 vs in vitro prostaglandin synthesis


					EB048G1S9J

THEOBROMA CACAO WHOLE

PARENT -> CONSTITUENT ALWAYS PRESENT

Comments:

Among the compounds tested in this study, N-coumaroyldopamine and N-caffeoyldopamine were the two most potent compounds, able to increase cAMP at the concentrations < 0.05 uM in U937 cells. The decreasing order of potency was N-coumaroyldopamine > N- affeoyldopamine > N-feruloyldopamine > N-sinapoyldopamine > N-cinnamoyldopamine.

Showing 1 to 2 of 2 entries

Previous1Next